Terbinafine

DRUG18 trials

Sponsors

Basilea Pharmaceutica International AG Allschwil, Novartis Pharmaceuticals, Merck Sharp & Dohme LLC, Roxane Laboratories, NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)

Conditions

Acute Kidney InjuryAntifungal Drugs in OnychomycosisCardiac Surgical ProceduresChronic Hepatitis bFungal ResistanceFusarium spp.Invasive mold infections caused by Aspergillus spp.Lomentospora prolificans

Phase 1

Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis

CompletedNCT00691184

NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)Onychomycosis/Onycholysis and Tinea Pedis

Start: 2005-02-28End: 2005-12-31Updated: 2008-06-05

Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis

CompletedNCT05578950

Combined Military Hospital AbbottabadOnychomycosis

Start: 2022-03-01End: 2022-08-31Updated: 2022-10-19

From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients

RecruitingNCT06295328

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Chronic Hepatitis b

Start: 2022-04-13End: 2025-04-01Target: 36Updated: 2025-02-07

Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis

Not yet recruitingNCT06400056

Assiut UniversityFungal Resistance

Start: 2024-05-31End: 2025-05-31Target: 30Updated: 2024-05-06

Phase 2

A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)

CompletedNCT00491764

Merck Sharp & Dohme LLCOnychomycosis

Start: 2007-06-30End: 2008-12-31Updated: 2017-04-07

Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis

CompletedNCT02606032

Hamilton Health Sciences CorporationUlcerative Colitis

Start: 2016-05-31End: 2021-01-27Updated: 2021-02-10

Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis

Post Graduate Institute of Medical Education and Research, ChandigarhTinea

Start: 2018-04-30End: 2019-01-31Target: 100Updated: 2018-05-01

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

RecruitingNCT07365423

Swiss Cancer InstituteRecurrent Prostate Cancer

Start: 2026-04-24End: 2030-10-01Target: 42Updated: 2026-07-16

Terbinafine for CSA-AKI Prevention

Not yet recruitingNCT07738328

Guangdong Provincial People's HospitalAcute Kidney Injury, Cardiac Surgical Procedures

Start: 2026-09-01End: 2028-05-01Target: 208Updated: 2026-07-31

Phase 3

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

CompletedNCT00443820

Novartis PharmaceuticalsOnychomycosis

Start: 2006-12-31End: 2008-06-30Updated: 2011-04-19

Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

CompletedNCT00443898

Novartis PharmaceuticalsOnychomycosis

Start: 2006-12-31Updated: 2012-05-03

Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis

CompletedNCT01433107

NovartisTinea Pedis

Start: 2011-08-31End: 2012-02-29Updated: 2013-12-27

Antifungal Drugs in Treatment of Onychomycosis

Assiut UniversityAntifungal Drugs in Onychomycosis

Start: 2017-07-01End: 2019-11-01Target: 60Updated: 2017-05-31

An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds

Not yet recruitingCTIS2024-516216-16-00

Basilea Pharmaceutica International AG AllschwilFusarium spp., Invasive mold infections caused by Aspergillus spp., Lomentospora prolificans +2

Target: 94Updated: 2025-12-01

Phase 4

Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis

CompletedNCT01851590

Helsinki University Central HospitalOnychomycosis

Start: 2013-10-31End: 2014-10-31Updated: 2015-11-30

Unknown Phase

Bioequivalency Study of Terbinafine Tablets Under Fed Conditions

CompletedNCT00602251

Roxane LaboratoriesOnychomycosis

Start: 2004-03-31End: 2004-04-30Updated: 2018-01-23

Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions

CompletedNCT00602342

Roxane LaboratoriesOnychomycosis

Start: 2004-03-31End: 2004-04-30Updated: 2018-01-23

Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.

CompletedNCT07068256

Muhammad Aamir LatifTinea Capitis

Start: 2025-04-01End: 2025-09-30Updated: 2025-11-28

Related Papers

Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis: A Qualitative Assessment of Patient Perceptions and Experiences

Journal of the Canadian Association of Gastroenterology2021-02-2612 citations

Pediatric Patient and Parent Perceptions of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis

Journal of Pediatric Gastroenterology and Nutrition2020-11-2014 citations

P018 Understanding Patients’ Perceptions of Fecal Microbiota Transplant

The American Journal of Gastroenterology2019-12-011 citations

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.

2011-12-0634 citations